贝康医疗出海产品系列Recently, the United States federal government announced a major medical reform, planning to include IVF treatment in the federal employee health benefits program by 2025, providing coverage of up to $25,000 for IVF and other reproductive treatment expenses for as many as 2.8 million federal employees and their families. In August, the California state legislative body also passed a bill requiring most private health insurance plans to cover IVF treatment; the same month, U.S. presidential candidate Trump also stated in an interview with NBC News that if elected, the government or insurance companies would cover all costs for IVF.
"We want more babies!" - Trump said in a speech on NBC News.
A series of signs indicate that the United States is expected to further expand the coverage of fertility insurance in the coming years, which also brings great opportunities for companies providing IVF-related product services globally. As the first listed IVD company in the domestic assisted reproduction field, Beacon Medical has been committed to providing high-quality reproductive health products to assisted reproduction centers worldwide. The latest report shows that Beacon's wholly-owned subsidiary Genea Biomedx (BMX) has nearly doubled its sales revenue in the North American market, and recently signed a large sales agreement with the well-known U.S. reproductive genetic medical device company Gattaca Genomics LLC, expecting to fully deploy Geri continuous culture incubators and related consumables software to Gattaca's 100 centers and laboratories within two years. The company also expects to launch a new round of international commercialization of frozen and genetic products by the end of 2024 to early 2025, providing strong impetus for the company's global development.
Beacon Medical's overseas product series
This rapid coverage of U.S. healthcare insurance will significantly increase the number of IVF cycles in North America, and Beacon products are expected to experience rapid growth shortly after entering the North American market. Against the background of encouraging fertility policies in various countries, Beacon Medical, with its complete industry chain layout in the assisted reproduction field, as well as continuous technological innovation and market expansion, is gradually becoming an important player in the international market.
